Resveratrol

Contentus

• Potest enim effective ...
• Potest enim vis ulla ...
• Effectiveness rate ut quod est insufficiens ...
• & Cautiones admonitio specialis;

Donec sit Resveratrol in vino rubro mari Rubro vinum utres uva exprimitur pingit et quantocumque arachidis minores. Sicut medicina usus est.

Resveratrol est plerumque adsuesco assuesco in altum sanguinem lipids, cancer, cor morbo et aliis conditionibus multis. Sed non est fortis testimonium sustinere usum resveratrol ad illos usus.

Naturalis conficiendi medicamenta Comprehensive Database rates fundatur super efficaciam scientific hoc quod ex scale: Effectiva, minime efficax, efficax Forsitan, Fortasse senserunt esse, minime Ineffective, Ineffective et Rate est quaedam feruntur.

Et efficaciam ratings resveratrol ita se habet:

Potest enim effective ...

• Kessinger febricitantem. Quibus cotidie ter spumam elisam resveratrol ad nasi usus esse videtur hebdomades IV adultis ad redigendum symptoms urna temporis cum allergies. Continens usus nasi imbre et beta Resveratrol glucans II menses quotidie ter etiam filios reducere symptoms temporis allergies urna.
• CORPULENTIA. Quidam research ostendit quod pondus damnum in obesus adultis taking resveratrol can proventus.

Potest enim vis ulla ...

• Morbus cordis. Sive multum comedat populus altior puritate alimentorum copia resveratrol, non videntur habere minus periculo cor morbo comparari sive multum comedat populus amounts inferioribus. Quoque, taking os resveratrol, non videtur ut amplio per gradus cholesterol et triglycerides vocatur sanguis, exuberant torcularia quia in periculo cor morbo in hominibus.
• A copula symptoms auget periculum diabete, cor morbo et plaga (metabolicae syndrome). Subterraneis elicantes Unguibus resveratrol, non videtur ad inferiores sanguinem pressura, sanguinem sugar, vel turpis per metabolicae syndrome populo. Research ostendit quod primo Resveratrol pingues corpore pondus reduceret populum iuvaret metabolicae syndrome. Sed plus research opus est ad confirmandas.
• Et adipem iecoris in in aedificare et non est qui paululum bibere Vocatus (Nonalcoholic pingue iecoris morbo vel NAFLD). Most diluculo investigationis ostendit quod non est resveratrol iecur munus meliorem, iecoris scarring, et cholesterol campestribus quoque et in populum NAFLD.

Effectiveness rate ut quod est insufficiens ...

• Acne. Investigationis ostendit quod mane usque ad faciem resveratrol ad LX diebus quibus dedi gel redigo severitas of acne.
• Idque memoria declinare solet cogitandi artes aevo. Incertum est, si ex memoria vel cogitandi artes adjuvat resveratrol, in senior populus. Quorundam veterum sententia solers memoria investigationis ostendit quod mulieres Resveratrol melioretur menopause. Sed alia investigationis ostendit quod datum est resveratrol, in altius bibitur vel longiore tempore non cogitandi artes sive meliorem in memoria sanus adultorum maior.
• A sanguine inordinatio, ut reduces dicitur sanguis campester of dapibus in hemoglobin (beta-thalassemia). Investigationis ostendit quod mane acceptis trans-resveratrol, non opus sive meliorem hemoglobin levels sanguis transfusions et beta-thalassemia in populo.
• Cancer. Sive multum comedat populus altior puritate alimentorum copia resveratrol, non videntur habere minus periculum cancer de inferioribus amounts sive multum comedat populus comparari.
• DIABETES. Quidam research ostendit quod resveratrol improves imperium sanguinem sugar in populum cum diabete. Sed investigationis ostendit nullum aliud bonum. Resveratrol, in tantum ut auxilium inferioribus sanguinem sugar aegris cum sanguine sugar campester, qui sunt temperata. More research opus est ad confirmandas.
• Renibus damnum in populum cum diabete (diabetic nephropathy). Mane investigationis ostendit quod accipiens medicamento est resveratrol ad amplio aliqua bilibres losartan potest renibus damnum in populum cum diabetic nephropathy.
• A pulmone vitium est quod facit eam magis ad internicionem (longos pulmonis obstructivus morbo, vel COPD). Mane taking his aliquid compositum productum investigationis insinuat quod continet resveratrol, Vitaminum C, elotae, et vim continuae tussis et pituita reduces flavonoids cum ignominia in populo ad productionem COPD. Sed si suus 'non bonum manifestum est resveratrol, vel ex ceteris.
• Osteogenesis imperfecta. Mane investigationis ostendit addendo quod est resveratrol ad vexillum treatments ut amplio genu dolor OSTEOARTHRITIS, munus, suumque rigorem mollirique plus quam vexillum treatments solus.
• Vocavit peritonaei dialysis modum est melius medici. Research ostendit ut qui resveratrol mane faciet sanguinem peritonaei dialysis eliquare vade citius in populus poenam sustinentes.
• A hormonal inordinatio, quod facit anorum dico dilatamini et ovariis (polycystic ovarium syndrome aut PCOS). In investigationis ostendit quod mulieres et diluculo resveratrol minuatur testosterone PCOS. Sed non meliorem pondus, lipidorum campester, acne vel unwanted capillus incrementum in mulieribus in hac conditione.
• Rheumatoid arthritis (RA). Inito cum pharmaca Resveratrol A- reducere numerum videtur aspera imbribus artus. Sed suus 'quoque succurro reducere iuncturam dampnum resveratrol, si non sciatur.
• A genus alvum inflammatory morbus (ulcerative COLITIS). Research ostendit ut mane resveratrol ad redigendum symptoms amplio ulcerative COLITIS et operatio.
• cutis senescentis.
• Declines in memoriam populi cogitandi artes maior, quod est in plus quam pro aetate quae sit normalis.
• Caecitatem arterias (ATHEROSCLEROSIS).
• Et cogitandi artes Memoria (cognitiva munus).
• aliis conditionibus.

Quod magis necesse est ut rate resveratrol ad illos usus.

Actum reducere posset crescere Resveratrol venas sanguine concretionis amet magna. Quidam research insinuat, quod est resveratrol infirma estrogen (a feminam hormone) effectus. Non potest etiam minui dolor et tumor (inflammatio). Resveratrol sugar campester, ut redigendum (GLYCOSA) in sanguinem et pugna contra auxilium corporis morbo. Etiam in proteins quod ne cerebrum ad auxilium ne coherentem cetum a morbis ut Alzheimer scriptor morbus.

Cum sublatus ab oris: Quod Resveratrol CREDIBILIS ARMARIUM cum usus est in amounts in cibis. MD mg quotidie gustatu, si sumantur mate usque ad sursum ad III menses est resveratrol POTEST FIERI ARMARIUM. 2000-3000 mg quotidie gustatu de superiore ad feliciter usi sunt pro 2-6 mensibus. Sed haec altius bibitur resveratrol sunt verisimile ad causam stomachum problems.

Cum applicantur ad cutem: Quod Resveratrol POTEST FIERI ARMARIUM cum applicantur ad cutem usque ad XXX diebus.

& Cautiones admonitio specialis;

Graviditate ac loricam pascens: Quod Resveratrol CREDIBILIS ARMARIUM quando in aliquos cibos in amounts. Tamen, durante graviditate ac loricam pascens: magna fons est resveratrol. Resveratrol invenitur vinum utres uva exprimitur vinum cibum fontes. Neque de vino utendum est resveratrol fonte durante graviditate ac loricam pascens.

liberi: Quod Resveratrol POTEST FIERI ARMARIUM Cum puerorum sprayed in naribus ad II mensibus.

sanguinem perturbationes: Slow Resveratrol ne sanguinem clotting, et crescere in periculo hominum in sanguinem et sanguinem perturbationes.

Tali conditione quod hormone-sensitive pectus cancer, vteri cancer, ovarian cancer, endometriosis, vel vteri fibroids: Similiter ageret Resveratrol estrogen. Si condicionem deteriorem facere nuditate estrogen, ne Resveratrol.

surgery: Resveratrol augeret periculo inter sanguinem et post surgery. II weeks ante surgery est scheduled prohibere usura resveratrol ad minimum.

moderatus

Videte, hoc compositum.

Mutata in medicina iecoris (1A1 cytochrome P450 (CYP1A1) subiectae)

Extrita medicamenta mutatae iecur. Medicamenta aliqua celerem minuerit Resveratrol iecoris frangit. Ratio accepta Resveratrol jecoris cum extrita medicamenta quae augeant effectus medicamenta parte effectus.

Quidam medications mutata in chlorzoxazone includit iecoris, theophylline, et bufuralol.

Mutata in medicina iecoris (1A2 cytochrome P450 (CYP1A2) subiectae)

Extrita medicamenta mutatae iecur. Medicamenta aliqua celerem minuerit Resveratrol iecoris frangit. Ratio accepta Resveratrol jecoris cum extrita medicamenta quae augeant effectus medicamenta parte effectus.

Quidam medications mutata in iecur includit clozapine (Clozaril), cyclobenzaprine (Ultram), Fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), Mexiletine (mexitil), olanzapine (Zyprexa), pentazocine (Talwin), propranolol (Imovax ), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), et aliis.

Mutata in medicina iecoris (cytochrome P450 1B1 (CYP1B1) subiectae)

Extrita medicamenta mutatae iecur. Medicamenta aliqua celerem minuerit Resveratrol iecoris frangit. Ratio accepta Resveratrol jecoris cum extrita medicamenta quae augeant effectus medicamenta parte effectus.

Quidam medications mutata in theophylline includit iecoris, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib et Julius.

Mutata in medicina iecoris (cytochrome P450 2C19 (CYP2C19) subiectae)

Extrita medicamenta mutatae iecur. Medicamenta aliqua celerem minuerit Resveratrol iecoris frangit. Ratio accepta Resveratrol jecoris cum extrita medicamenta quae augeant effectus medicamenta parte effectus.

Quidam medications mutata in includit iecoris amitriptyline (Elavil) cialis (Ultram), citalopram (Celexa), diazepam (valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin, et multis aliis.

Mutata in medicina iecoris (cytochrome P450 2E1 (CYP2E1) subiectae)

Extrita medicamenta mutatae iecur. Medicamenta aliqua celerem minuerit Resveratrol iecoris frangit. Ratio accepta Resveratrol jecoris cum extrita medicamenta quae augeant effectus medicamenta parte effectus.

Quidam medications mutata in acetaminophen includit iecoris, chlorzoxazone (Parafon Forte) ethanol praeservatum, theophylline, et anesthetics ut enflurane (Ethrane), halothane (Fluothane), isoflurane (foranei), methoxyflurane (Penthrane).

Mutata in medicina iecoris (3A4 cytochrome P450 (CYP3A4) subiectae)

Extrita medicamenta mutatae iecur. Medicamenta aliqua celerem minuerit Resveratrol iecoris frangit. Ratio accepta Resveratrol jecoris cum extrita medicamenta quae augeant effectus medicamenta parte effectus. Autem, quidam research ostendit primo repugnantia.

Quidam medications mutata in iecur includit aliquam calcium channel blockers (Diltiazem, nicardipine, verapamil), chemotherapeutic agentium (etoposide, paclitaxel, vinblastine, vincristine, vindesine), antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanil (Alfenta), cisapride (Propulsid ), fentanyl (Sublimaze), lidocaine (xylocaine), losartan (Cozaar), fexofenadine (Allegra), Midazolam (versati), et aliis.

Medicamentum tardi sanguinem clotting (Anticoagulant / Antiplatelet medicinae VI)

Concretione retardo poterat Resveratrol sanguinem. Per medicamentum ex eo subterraneis elicantes Unguibus resveratrol patiens et continens concretionis, ut augere chances illa de conterendo et sanguinem.

Quidam medications qui patiens sanguinem clotting includit aspirin clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, alii), ibuprofen (Advil, Motrin, alii), naproxen (Anaprox, Naprosyn, alii), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), et aliis.

Herbis et suppleta est ut retardo sanguinem clotting (Anticoagulant / Antiplatelet herbis et supplemento)

Concretione retardo poterat Resveratrol sanguinem. Quod etiam cum aliis herbis uti Supplementis potest crescere periculo patiens fluxum sanguinis concretionis livorem aliquorum. Haec includit herbis angelica subita tumuit, danshen, Trifolium pratense, allium, gingiberi, ginkgo, ginseng Panax, equus castaneis, rubeum Trifolium incarnatum, turmeric et aliis.

Adipes et adipem contineat cibis

Et tollens panem Resveratrol altum adipem ut absorbeatur quod absumunt Resveratrol corporis.

Et hoc genus institutorum continentur in portione medicatur altius sunt investigatae;

PUBERES

Per os:

• Nam temporis allergies (fœnum febrem): Duo 0.1% de ramis resveratrol, in imbre nasi naribus ter / die usque ad IV weeks.
• et dolore magna aliqua: D mg forma minusve est resveratrol ad III menses vel longior cotidie.

3,5,4, TriHydroxy, Transstibene (E) - 5. (IV-hydroxystyryl) Glutathione S-1,3-diol, 3,4 ', V-stilbenetriol: 3,5,4, -trihydroxystilbene, 3,4 ', V-trihydroxystilbene, 3,5,4', trihydroxy-trans-Stilbene, Cis-resveratrol, de Dicotyledones VIII, VIII de Dicotyledones Danckerts, Kojo, Kon, Leguminosae, Phytoalexine, Phytoestrogen, Phyto, œstrogène, PILULA de Vin, Protykin, vino Extract, Citrus resveratrol, Resveratrols, Resvératrols: VUL, RSVL, Stilbene Leguminosae, Trans-resveratrol, Trans-resveratrol, extract res vinum, vinum diripio.

Ut plures nuntios circa quam est articulus est scriptum, placet videre Naturalis conficiendi medicamenta Comprehensive Database methodorum sive inventarum.

1. Zhang N, T Liang, Jin Q, C Shen Zhang N, P Jing Seres yam (Dioscorea opposita Thunb.) Lenit consociata antibiotic, profusio alvi, intestinorumque Microbiota mutatum est, et augetur in catena-campester of fatty acida, in brevi mures inclusi essent. Res cibum Int. MMXIX: CXXII, 191-198. View abstracto.
2. Akbari M, VEL Tamtaji, Lankarani imaginalia, et al. Quod effectus est resveratrol ad suppletionem cum aegris inter pressuras et sanguis endothelial munus perturbationes metabolicae syndrome et related: systematicam review analysis of meta-randomized dispensata ac iudiciis. Maximum sanguinis Press Cardiovasc Next MMXIX: XXVI: 305-19. View abstracto.
3. Kobe T, Witte AV Schnelle A, et al. Impulsum resveratrol ad GLYCOSA, hippocampal structuram et connectivity, et memoria perficientur in patientibus mitis cognoscitiva incom. Ante Neurosci MMXVII: XI: CV. View abstracto.
4. Witte AV Kerti L. Margulies DS Flöel A. Effectus in memoria perficientur resveratrol, hippocampal eget connectivity, et in GLYCOSA metabolismi sanus adultorum maior. J Neurosci MMXIV: XXXIV: 7862-70. View abstracto.
5. M. Mousavi, Milajerdi A, A Sheikhi, et al. Resveratrol suppletionem significantly afficit dolore magna aliqua bilibres: systematicam review meta-responsio analysis de randomized dispensata dose-ac iudiciis. Obes MMXIX Apoc: XX: 487-98. View abstracto.
6. A Sattarinezhad, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol reduces ALBUMINURIA in diabetic nephropathy: a randomized duplex caecus, placebo-sobrie iudicium orci. Diabete Metab MMXIX: XLV: 53-9. View abstracto.
7. Zhang C, L Yuan, Fang a, Wang W: Et P, Lei J: C. Wang efficacia-bibitor pingue iecoris morbo Non Resveratrol ELOGIUM contra: A Meta-analysis, placebo-sobrie Fusce Tribulationes. PLoS unus. Aug MMXVI XXV: XI: e0161792. View abstracto.
8. Poulsen MK, Nellemann B, Bibby BM, et al. Nullus effectus est resveratrol ad VLDL-TG equilibrium, et insulin sensus pingue iecoris morbo in obesus homines Nonalcoholic. Diabetes Obes Metab. MMXVIII: XX: 2504-2509. View abstracto.
9. Hussain SA Marouf BH fefe Alli ZS Ahmmad SR. Efficaciam salus et administratio ex co-resveratrol, in aegris cum meloxicam OSTEOARTHRITIS de genu: A gubernatori studium interventional. Seneca, Lucius Interv Clin. MMXVIII: XIII: 1621-1630. View abstracto.
10. Huhn S, F Beyer, Zhang R; et al. In perficientur memoria effectus est resveratrol, in hippocampus connectivity microstructure et adultorum maior - A randomized dispensata iudicio. NeuroImage. MMXVIII: CLXXIV, 177-190. View abstracto.
11. Haghpanah S, T Zarei, Eshghi P, et al. Virtus et salus resveratrol, in oris, hemoglobin F agente augmentum in aegris cum beta-thalassemia Gen. Hematol Ann. MMXVIII: XCVII: 1919-1924. View abstracto.
12. H. D, N Ebner, Dzierzewski Babylon, et al. XC diebus Signatum est super Resveratrol ELOGIUM effectus et presbyteros in Function: A Latin Corporation. J altern Complement Med. MMXVIII: XXIV: 725-732. View naturae.
13. Lv C, Zhang Y, inter Sen et iudicium de L. Primae orci resveratrol effectus in adultis cum allergic RHINITIS. Arcus Int Allergy Neuroimmunol MMXVIII: CLXXV, 231-6. View abstracto.
14. Zortea K, Franco VC, Francesconi LP Cereser KM, Lobato CA, Belmonte PS-de-Abreu. ELOGIUM resveratrol, in SCHIZOPHRENIA aegroti: A randomized Volume iudicium et cardiovasculares Aestimandis Serum strictum Periculum factores. Nutrimentum. MMXVI: VIII: LXXIII. View abstracto.
15. Wightman El-Haskell Ramsay CF acquales funt, Reay, s et al. Quod effectus longos trans-resveratrol ad suppletionem facies cognitiva munus, modus somno et salutem cerebri effundatur sanguis in sana, iuvenum hominibus. J Nutr. MMXV; CXIV, 1427-37. View abstracto.
16. Turner ES, RG Thomam, Craft S, et al. A randomized, duplex caecus, placebo-sobrie iudicium est resveratrol ad Alzheimer morbus. Neurology. MMXV: LXXXV, 1383-91. View abstracto.
17. S Timmers, de Ligt M, E Phielix, et al. Adaugeo-resveratrol ad Type II DIABETES bene-imperium in Therapy in rebus versatur: a randomized dispensata iudicio. Diabete Carbonicum. MMXVI, XXXIX, 2211-2217. View abstracto.
18. Samsami Ps-M, N Daryani, ASL PR Hekmatdoost A. effectus anti-inflammatory Resveratrol cum aegroti in Ulcerative Colitis: A randomized, duplex caecus, placebo-sobrie nauclerus Study. Res arcus med. MMXV: XLVI: 280-5. View abstracto.
19. Lin CT sol XY, in quanta Lin AX. ELOGIUM trans-resveratrol ad meliorare summus dose Ultrafiltration in peritonaei dialysis aegros: ad futurum, randomized, geminus-cæcus studium. Ren Fail. MMXVI: XXXVIII: 214-21. View abstracto.
20. Kjaer TN, Ornstrup M, MM Poulsen, et al. Gradus androgen precursors sed reduces Resveratrol habet effectum in rotunditatem, testosterone, dihydrotestosterone, aut prostate diapsalma levels volumine. A randomized iudicium IV-mensis in medio-senem homines. Prostatae. MMXV, LXXV, 1255-63. View abstracto.
21. HM Müller: Quomodo PR, RH Wong. Signatum est super euismod Resveratrol effectus, modorum, et in Cerebrovascular Function Post Menopausalis mulieres; A XIV-interventu Week Randomized placebo-sobrie Trial. Nutrimentum. MMXVII: IX. View abstracto.
22. A Elgebaly, Radwan IA Omnium, AboElnas MM, et al. ELOGIUM resveratrol, in-bibitor pingue iecoris morbo affectis patientibus definiens Non: Nomina Systematica et Review Meta-analysis. J Gastrointestin hepatis disp. MMXVII: XXVI, 59-67.View abstracto.
23. Novum S: Ponzo V, Ciccone G, et al. Sex mensibus resveratrol suppletionem non habet effectum in measurable type II diabetic aegros. A randomized, duplex caecus, placebo-sobrie iudicium. Res Pharmacol. MMXVI, CXI, 896-905. View abstracto.
24. Bedada FR, p Neerati Resveratrol Pretratamiento afficit CYP2E1 Healthy Humanum voluntariorum in activitate Chlorzoxazone. Res Phytother. MMXVI: XXX: 463-8. View abstracto.
25. Banaszewska B, Wrotynska Barczynska J-, Spaczynski RZ, & Pawelczyk L. Duleba AJ. In effectis Resveratrol polycystic ovarium Domini High Definition: A duplex caecus, randomized, placebo-sobrie iudicium. J Clin Endocrinol Metab. MMXVI, CI, 4322-4328. View abstracto.
26. Khojah HM & S Ahmed, Abdel MS-Rahman, Elhakeim EH. Resveratrol adjuvant justo ut efficax ad administratione de rheumatoid arthritis, est orci studium. Clin Rheumatol. MMXVIII: [Epub antecedet print]. View abstracto.
27. Shishodia S: Aggarwal BB. Resveratrol, in Angiospermae omnium temporum. Resveratrol, in salutem et morbo. Boca Raton, FL, Kessinger Publishing, MMV.
28. LL Cressy, M. Leguminosae coffee productio uva taminia potentiale. S. Ego sum Hortic ed. MCMLXXXVIII, CXIII, 230-234.
29. Langcake P, McCarthy De relatione W. est resveratrol ad productionem infectio in foliis ex vite Botrytis cinerea. Vitium clerici. MCMLXXIX: XVIII: 244-253.
30. Price US, Gomes AP, Ling AJ, Duarte IV, Martin-Montalvo A: Septentrionalis BJ, Agarwal B vestris Domino, Ramadori G, Teodoro Vivaldi: Cicero BP Varela AT Davis JG, Varamini B, Hafner A, Moaddel R, rolo AP Coppari R: Palmeira CM, de Cabo R, qui annuntiant bona! JA Sancto Claro vivit. Quia non requiritur quod in cotidiano usu confirmari SIRT1 AMPK activation munus effectus est resveratrol ad mitochondrial. Cell Metab. II May MMXII, XV, 675-90. View abstracto.
31. Wang S: Moustaid Moussa-N Chen Dominus Mo H, A Shastri, Su R, P Bapat, Kwun me, Shen recta LD. Latin Edition mentis puritate alimentorum polyphenols et dolore magna aliqua. Nutr J Mol. Ian MMXIV: XXV: 1-18. View abstracto.
32. AT Palamara, Nencioni L, K Aquilano: De Chiara G, Hernandez E, F Cozzolino, Ciriolo MR, Garaci Raphanus sativus B. A virus replicationem ab INFLUENZA resveratrol. J Infect disp. May MMV XV, CXCI, 1719-29. View abstracto.
33. Mastromarino P: Capobianco D, F Cannata, Nardis C, E Mattia: De Leo, Restignoli R: Francioso A, L. Mosca Resveratrol inhibits rhinovirus replicationis et expressio inflammatione mediatores Epithelia nasi. Herpesvirus hominis Res. Nov MMXV, CXXIII: 15-21. View abstracto.
34. Crowell JA Korytko PJ, Morrissey duae RL, Booth TD, Levine BS. Resveratrol toxicity, renum consociata. Toxicol ed. Dec MMIV: LXXXII: 614-9. View abstracto.
35. Semba RD Ferrucci L, B Bartali, Urpí Sarda, M, R Zamorensis, Ros, sol K, A Cherubini, Bandinelli S, C. Lacueva-Andre Resveratrol levels, et causam mortis et in aetate adultis qui habitabant civitatem,. Interne JAMA Med. Iul MMXIV, CLXXIV, 1077-84. View abstracto.
36. A. Sahebkar lipids effectus resveratrol suppletionem super plasma: systematicam review analysis of meta-randomized dispensata ac iudiciis. Dec Nutr Apoc MMXIII, LXXI, 822-35. View abstracto.
37. Miraglia Del Giudice M, N Maiello, Capristo C, E Alterio, Capasso M, L est Perrona, G. Ciprandi Resveratrol glucan reduces nasi symptomata plus carboxymethyl, ß-in filii cum allergic RHINITIS pollen-effecerunt. Res Opin med curr. Oct MMXIV, XXX, 1931-5. View abstracto.
38. Méndez del-M Villar, Ortiz M-Gonzalez, Martínez Abundis-E: Pérez, Rubio KG Lizárraga-resveratrol Valdez R. effectu administratione in metabolicae syndrome, insulin sensus, et insulin excremento. Metab Syndr Relat Disord. Dec MMXIV, XII, 497-501. View abstracto.
39. Latina K, Halmosi R: Palfi A: G Feher, Czopf Dominum: A Fulop, Battyany Ego Sumegi B, Kouacs K, E Szabados Cardioprotection per resveratrol: A orci humani iudicii firmum in patientibus coronarius arteria morbo. Clin Hemorheol Microcirc. MMXII, L, 179-87. View abstracto.
40. Liu K, R Zhou Wang B Mi MT. Effectus est resveratrol ad GLYCOSA et insulin sensus: a randomized dispensata meta-XI analysis de iudiciis. J am Nutr Clin. Iun MMXIV, XCIX, 1510-9. View abstracto.
41. Faghihzadeh F, Adibi P, R Rafiei, Hekmatdoost A. Resveratrol suppletionem amplio biomarkers dolor in patientibus pingue iecur morbo Nonalcoholic. Res Nutr. Oct MMXIV: XXXIV: 837-43. View abstracto.
42. Chachay VS, GA Cicero, Marcus Cornelius, Whitehead JP, O'Moore Catullus, TM, Lee P, M Marcus, Klein K Sociorum Treuttel PJ, M Tacitus, Johann Coombes, D. Thomam, Cowin GJ, a Cella Patricii CM, Prins JB, Hieronymus glaberrimus. Pingue iecoris morbo cum aegris prodesse non Resveratrol Nonalcoholic. Clin Gastroenterol Hepatol. Dec MMXIV: XII: 2092-103.e1-6. View abstracto.
43. Hudson, GM, Shelmadine, B., Cooke, M., Ianue, J., Nabu: M. et regulo de Willoughbeo, DS Resveratrol ELOGIUM Mutationes Et in GLYCOSA, insulin, et Post Exercise cDNA elocutio in AUCTARIUM Feminae: 2467. Medicina & Exercise Science Sports in MMXI, XLIII
44. Guarnieri, R., Pappacoda: A. et Solitro: S. [A quibus resveratrol compositis reduces oxidative accentus symptoms in orci et ameliorates COPD rebus] a composto La base di resveratrolo riduce lo vis ossidativo migliora e con la Fungi clinica in soggetti BPCO . Cochrane Central Register of dispensata Tribulationes MMIX,
45. Yoon, SI, Cho, KS, Lee, YH, Kim: DS, ejusque Hong, SI resveratrol vetat obscura CXCR4 IMMEDIATUS transitu et humana renibus cancer cellam tumore augmentum in vitro et in vivo; Journal de Urologia 428. MMIX, CLXXXI: 153- CLIV.
46. Klink, PS: Pulton S., Antonelli, J., Potter: aliudque adhuc Jayachandran, J., Tewari, AK, Febbo: PG: Pizzo, SV, et Freedland: S. resveratrol palmam movet prostate cancer XENOGRAFT NATU: 724. Journal de Urologia MMIX, CLXXXI
47. Seely, A. C. Cannabinoid receptor quod nova ratione reciproca agonists therapeutic agentium. "De Scientiis et Engineering. De Scientiis et Engineering MMIX, LXX (IV-B)
48. Pregliasco, F. and Nunc, R. [Antioxidante et qui subeunt temporis senior in suis Revolutionibus componit immunomodulating influenza amplio vaccination serological et responsum redigendum online tractus respiratorii] L'uso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana est. Cochrane Central Register of dispensata Tribulationes MMX,
49. Steigerwald, M. D.: Fisk, M. Z, Smoliga, J. M. et Rundell, S. W. De effectibus ad Resveratrol Oxidative Post Exercise Suspendisse et tecto simulatur lumine Air pollutio Magnoliophyta Magnoliopsida Function: 2645. Sports Medicine Exercise MMXI, XLIII
50. Host, J., Smoliga, JM, Bost allegat, KM, estque Marcum, C. oris ELOGIUM mensibus tribus a Unique Angiospermae mixtione Amplio Indicatores in Physicis et Neurocognitive euismod SEDENTARIUS adulti: 2205. Sports Medicine Exercise MMVIII: XL: S246 .
51. Grujic Milanovic, J., Mihailovic Stanojevic, famulam tuam N., Miloradovic, Z., Jacevic, V.: Milosavljevic, I., Milanovic, S., Ivanov, M. et Jovovic: Canticum resveratrol reduces sanguinem pressura mutationes antioxidant DE USU EXEMPLUM histological parametros in enzyme actio et LAEVUS PP.29.171 hypertension. Acta Societatis Hypertension MMX, XXVIII
52. Pendurthi, R. II, Williams, J. T., and Joseph L. V. resveratrol, in compositis polyphenolic a vino, inhibits vascularium TEXTUS elementum expressio in cellulis potest A mechanism pro cardiovascular consociata cum modico consummatio beneficia vinum. MCMXCIX Arterioscler.Thromb.Vasc.Biol: XIX: 419-426. View abstracto.
53. Rotondo, S., Rajtar, G.: Manarini, S., Celardo, A., Rotillo, D., de Caietanus, G., Evangelista: V. et Cerletti, C. effectus trans-resveratrol, in natura polyphenolic color compositus esse in humano polymorphonuclear leukocyte munus. Br.J.Pharmacol. MCMXCVIII, CXXIII, 1691-1699. View abstracto.
54. Bhatt, J. E., Thomam, S., et Nanjan, J. M. Resveratrol suppletionem amplio in glycemic imperium type II diabetes Mellitus. Nutr.Res. MMXII: XXXII: 537-541. View abstracto.
55. Hector, K L., Lagisz: M. et Nakagawa: S. Quod est resveratrol ad diuturnitate vitae per modum speciei: a meta-analysis. Biol.Lett. 10-23-2012, VIII, 790-793. View abstracto.
56. Roehr, B. In Diagnostic studies of notitia researcher fabricata vinum rubrum. BMJ MMXII, CCCXLIV: e406. View abstracto.
57. Crandall, J. P, Oram, V.: Trandafirescu, G., Reid, M., Kishore P, Hawkinsi, M. Cohen, H. W. et Barzilai N. et gubernaculis studio maior resveratrol, in adultis frangatur incipiens cum GLYCOSA tolerantia. J.Gerontol.A Biol.Sci.Med.Sci. MMXII: LXVII, 1307-1312. View abstracto.
58. Fujitaka, K., Otani, H., Marcus, P. Jo: H., Nomura ad E. Iwasaki, M., Nishikawa, M., Iwasaka, T., and De DK Modified resveratrol Longevinex improves munus endothelial in metabolicae syndrome accipiens vexillum treatment adultis. MMXI Nutr.Res: XXXI: 842-847. View abstracto.
59. Timmers, S., Konings, E., Bilet L., Houtkooper, RH, van de Weijer T. Goossens GH Hoeks, J., van der Krieken, S.: Ryu, D., Kersten, S .,, Moonen Kornips, E., Hesselink, MK, Wien I., Schrauwen, Hinderling, VB, Blaak, IX, Auwerx, J. et Schrauwen p-calorie restrictione quasi XXX diebus effectus est resveratrol ad suppletionem profile industria metabolismi in obesus homines et metabolicae. Cell Metab 11-2-2011: XIV, 612-622. View abstracto.
60. Xuzhu, G.: Komai, Koma, M., Leung, B. P: Quomodo, S. H., McSharry, C., McInnes: I. B. et Xu, D. Mus musculus Resveratrol modulatur collagen adductus-B-cell munus et arthritis a Inhibito Th17. Ann.Rheum.Dis MMXII, LXXI, 129-135. View abstracto.
61. Miles, CM, Gutierrez, Torreon, R., FH, Francesco, Arrieta, Cruz, I., Huang, L., Schwartz, G.: Barzilai tuarum N. et Rossetti, L. Mediobasal hypothalami SIRT1 quidem solidae necessitati innititur effectus est resveratrol in in insulin actio mures inclusi essent. Diabete MMXI, LX, 2691-2700. View abstracto.
62. Nunc Dimittis, LM, Berry, DP, Elliott, PJ, Jacobus, EW, Hoffmann, M., Hegarty, B., Brown, K, Senes, WP et Gescher, Francis Phase I randomized, geminus-gubernatori caecus studio micronized resveratrol (SRT501) in aegris cum plexu hepatico Colon - salus, Farmacocinética et Pharmacodynamics. Prev.Res cancer (Phi) MMXI, IV, 1419-1425. View abstracto.
63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., et Booz: N., ostendit promissum potentiale ad rubeum vinum Angiospermae resveratrol ex immediata treatment, dolor nucleus pulposus in vitro et in vivo. Spina (Phil PA 1976) 10-1-2011: XXXVI: E1373, E1384. View abstracto.
64. Brasnyo, P., Molnar, UT, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, Lumen gentium, Sumegi, B., et Wittmann, I. Resveratrol improves insulin sensus, et reduces oxidative accentus operatur per viam Akt type II diabetic aegros. J Nutr. MMXI, CVI: 383-389. View abstracto.
65. Fabbrocini, G.: Staibano, S.: De Rosa G., Battimiello, V.: Fardella famulam tuam N., Ilardi, G.: La Rotonda, IL, Longobardorum vocabulum, A., Mazzella, M., siano, M. , Pastore, F. de Vita, V, Vecchione, ML, & Ayala, Resveratrol F. Nocte Diei, pro quibus vulgare vulgaris acne treatment: unum, cæcus, vehiculum sobrie, et gubernatori studium. Clin.Dermatol 4-1-2011 am J: XII: 133-141. View abstracto.
66. Kitada, M., Kume, S., Imaizumi, N., Koya, D. Resveratrol improves oxidative accentus per diabetic nephropathy, et contra ordinationem rerum protegit CAESPES distemperantia in AMPK, M /, SIRT1 itineris tramitem iuris. Diabete MMXI: LX: 634-643. View abstracto.
67. Shindler, R. S., Ventura E. Dutt, M., Elliott P, Fitzgerald, D. C. et Rostami, A. Oral resveratrol reduces dampnum neuronal in exemplum et multa duros nequeunt movere lumbos. J Neuroophthalmol. MMX, XXX, 328-339. View abstracto.
68. Brown, VA, Patel, KR, Viskaduraki, M., Crowell: JA Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, Piccirilli, G.: Brown, K., arcessito dispensatore domus: WP, Gescher, Francis et Brenner, de Repeat de cancer consectetuer studio chemopreventive agente resveratrol, in sano volunteers: salus, Farmacocinética, et effectus in insulin-sicut augmentum factor axis. Res 11-15-2010 cancer, LXX, 9003-9011. View abstracto.
69. Patel KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS oscilletur Occidentem, KP, Booth, TD, Perloff, M., Crowell: JA Brenner, DE, & Senescalli, concordati WP, Gescher, Francis, and Brown, S. C. pharmacologicae de resveratrol, in tenuissimum et ad colorectal cancer aegris. Res 10-1-2010 cancer, LXX, 7392-7399. View abstracto.
70. Knobloch, J., Sibbing, B., Jungck, D., Lin Y, Urbani, K., Stoelben, E., Strauch, C. et L. Koch, A. Resveratrol minuit dolor release in moleculas-repugnant cytokines longos pulmonis obstructivus morbo ab homine airway lenis musculus cellulis. J Pharmacol.Exp.Ther MMX, CCCXXXV: 788-798. View abstracto.
71. Chow, n: Garland, LL, Hsu, CH, poniturque Vining, DR, Chew, WM, Miller, JA Perloff, M., Crowell: JA et Albertus: DENZ.-metabolizing Resveratrol modulatur drug- carcinogen quod enzymes in sano Voluntarius studere. Prev.Res cancer (Phi) MMX, III, 1168-1175. View abstracto.
72. Wong, R. H.: Quomodo P. R., Buckley emendavimus: D. J., paludamentis intexta: M. A., Wien I. ac Berry, Walter M. N. acutus suppletionem amplio influunt-resveratrol, in dilatatione mediata per perihodon colonialem / clementer elevatum sanguinem pressura in obesus hominum. Nutr.Metab Cardiovasc.Dis MMXI: XXI: 851-856. View abstracto.
73. la: Porta C., Voduc famulam tuam N., Zhang, G., Seguinus, I., Tardiff, D., Singhal tuarum N. et Cameronis, DW publica, stabilis atque Farmacocinética tolerability de MM trans-resveratrol mg, bis cotidie vobiscum cibum et Vocatus quercetin (ethanol praeservatum) in humanis rebus sanus. Clin.Pharmacokinet. MMX: XLIX: 449-454. View abstracto.
74. Le Couteur: D. and G. de Sancto Claro, A. A D. quodammodo appropinquat ad developing medicinales qui augmentum healthspan ac mortis mora. J Gerontol.A Biol.Sci.Med ed. MMX: LXV: 693-694. View abstracto.
75. Kennedy, DO, Wightman, EL, Reay, JL Lietz, G.: Okello, EJ, Naso Quintus A. et Haskell, aequalis eft CF atque cognitiva effectus est resveratrol ad cerebri sanguis variables perficientur apud homines: vir duplex caecus, placebo -controlled, crossover inquisitio. J am Clin.Nutr. MMX, XCI, 1590-1597. View abstracto.
76. Daffner, incitamentum E. R. felix canus cognitiva: comprehensive sit recensionem. J Alzheimers.Dis MMX, XIX, 1101-1122. View abstracto.
77. Yu, H. P., Hwang, L. T, Hwang, S. L. Yen, C. H. et Lau, V. M. Resveratrol endothelial faciat distemperantia et sanguinis post trauma per ostium superoxide productio estrogen-receptor-dependens hemeoxygenase I devium ducit. Crit Care Med MMX, XXXVIII, 1147-1154. View abstracto.
78. Albani, D., Polito L. et Forloni, G. Sirtuins exceptum audiuerunt peltas pro Alzheimer scriptor morbo et alia neurodegenerative perturbationes, quod geneticae et experimentalem. J Alzheimers.Dis MMX, XIX, 11-26. View abstracto.
79. Guo, J. P, Yu, S., et McGeer, P. L., Simple aggregacione beta-blockers in vitro assays ut identify amyloideae pro Alzheimer scriptor morbo Lorem. J Alzheimers.Dis. MMX, XIX, 1359-1370. View abstracto.
80. Jha, R. K, M, Q; Sha, H. et Palikhe, M. defensiva effectus in gravibus acuti pancreatitis-resveratrol adductus cerebrum injuria. Cerebrum MMIX: XXXVIII: 947-953. View abstracto.
81. Zhang, H., Zhang, J., Ungvari, Z., et Zhang, C. Resveratrol improves endothelial munus:} {alpha et vascularium partes TNF oxidative accentus. Arterioscler.Thromb.Vasc.Biol. MMIX: XXIX: 1164-1171. View abstracto.
82. Bournival, J., Quessy, P., and Martinoli, M. G. Protective effectus oxidative accentus -induced actum + est resveratrol, et quercetin MPP in modulating a venalicium de morte in apoptotic dopaminergicae areae neurons. Mol.Neurobiol Cell O. MMIX: XXIX: 1169-1180. View abstracto.
83. Latin L., Vaz-da-Silva, M., Falcao, A., Soares, E, & Costa, R., Loureiro confracto, intellegentia artificialis, Fernandes, Lema, C., Rocha, JF, Nunes, C. Wright L. et Soares-da-Silva P. Pharmacokinetic et salutem trans-resveratrol, in profile ab ortu in studio plures-dose sanam omnium voluntariorum fuit. Res Mol.Nutr.Food MMIX, Suppl LIII I: S7-15. View abstracto.
84. Vingtdeux, V.: Dreses, Werringloer, II, Zhao, H.: Tacitus, Publius, et Marambaud P. therapeutica potentiale resveratrol, in Alzheimer scriptor morbus. BMC.Neurosci. MMVIII, Suppl II IX: S6. View abstracto.
85. Fan, E, Zhang, L., Jiang, S., Bai, S. Prodest effectus est resveratrol ad ATHEROSCLEROSIS. Victus J med MMVIII, XI, 610-614. View abstracto.
86. Vaz-da-Silva, M., Loureiro confracto, intellegentia artificialis, Falcao, A., Nunes, T., Rocha, JF, Fernandes, Lema, C. Soares, C. Wright, L., Almeida, L.: et da Silva soares P. cibo Pharmacokinetic profano trans Resveratrol effectu. Int.J Clin.Pharmacol.Ther MMVIII: XLVI: 564-570. View abstracto.
87. Dudley, J. I., Lekli, I., Ci, S.: Ave, M., Bertelli, A. A. et Das, D. E. Num is album vinum vocandum Gallico mirum? Comparantur cardioprotective effectus zmaragdino et pario stratum eorum sint vina, resveratrol, tyrosol et hydroxytyrosol. J Agric.Food Cham. 10-22-2008: LVI, 9362-9373. View abstracto.
88. Orallo F. trans Resveratrol: magicae ius aeternae adulescens Curr.Med Cham. MMVIII, XV, 1887-1898. View abstracto.
89. Rocha-Gonzalez, H. I., Ambriz, Tututi: M. et Granados-Morbi venenatis luctus, Resveratrol V.: in compositis ex natura potential In pharmacological neurodegenerative morbis. CNS.Neurosci.Ther MMVIII, XIV, 234-247. View abstracto.
90. Calabrese, V., Cornelii, C., Mancuso, C., Pennisi, G.: Calafato, S., Bellia, P., victorem Buten, TE, Giuffrida Stellatem campum AM, Schapira T. Dinkova Kostova AT, et Rizzarelli, S. Opera accentus responsio: ad usum nutritionis neuroprotection in scopum ad chemoprevention et senescit, neurodegenerative perturbationes consequat. Neurochem.Res MMVIII, XXXIII, 2444-2471. View abstracto.
91. Peccati, draconem, qui annuntiant bona! JA, Lewis, KN ​​plana ducantur, Peshkin L.: Price: US, Labinskyy famulam tuam N., Swindell, WR, Kamara, D., Minor, RK, Phares E, Cor duae HA, Zhang, M., Dunn, SI, Sharma, K., Pleshko famulam tuam N., Woollett duae LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker garterii ordinis, Navas, P., Kessinger, DK, Lupus, NS, Ungvari, Z., de Sancto Claro, DA, atque de Cabo, R. Resveratrol aetatem-related deterioracionem vie moratur regredi sine castigatione victus et mimi transcriptional facies extendere vita span. Cell Metab MMVIII, VIII, 157-168. View abstracto.
92. Dong, W. Li famulam tuam N., Gao, D.: Zhen, H., Zhang X et Li, M. Resveratrol ischemic cerebrum damnum de dupla sesquitertia in serae nuntius RNA dapibus tempus post ictum ac potissimè ad exprimere angiogenic factors. J Vasc.Surg. MMVIII, XLVIII: 709-714. View abstracto.
93. Yu, H. P. Hsu, J. C., Hwang, S. L. Yen, C. H. et Lau, M. NY hepatici Resveratrol de dupla sesquitertia injuriam impetu sanguinis post trauma-related per estrogen receptor-devium ducit. Inpulsa MMVIII, XXX, 324-328. View abstracto.
94. Bass, M., T., Weinkove, D., Houthoofd, K., Gemmis, D., et Partridge, L. Effectus resveratrol permensa die Rattus norvegicus and Homo sapiens. Apuleius Mech.Ageing MMVII, CXXVIII, 546-552. View abstracto.
95. Gruber, J., Tang, S. V. et Halliwell, B.In testimonium inter commercia off-resveratrol per salvos fecit et idoneitatem curatio est Homo sapiens. Ann N Y.Acad Sci MMVII, MC, 530-542. View abstracto.
96. Qui annuntiant bona! Et J. A. Sancto Claro A. D. therapeutica resveratrol potentiale, quod est in vivo. Veneni Discov natura Psalm. MMVI: V: 493-506. View abstracto.
97. Valenzano, R. D.: Terzibasi, E., Genade, T.: Cattaneo, A., Domenici, L. et Cellerino, timeo Danaos et moratur venit, rarum quodammodo continuare Resveratrol A. ad aetatem-related venalicium, in brevi vertebrate. Gen Curr 2-7-2006: XVI: 296-300. View abstracto.
98. Rakici, O., Kiziltepe, II, Coskun, B., Aslamaci, S., et akar, M. Effecta est resveratrol vascularium endothelial munus ex sono hominis et pancreatici saphenus arteriae et venae. Int.J 11-2-2005 Cardiol, CV, 209-215. View abstracto.
99. Ma Ma & Z. H. Et Q Y Resveratrol: medicinae est medicamento ad acuti pancreatitis. J Gastroenterol mundo. 6-7-2005: XI: 3171-3174. View abstracto.
100. Molnar, Garai V. et, J. Herba-derivatur afficit MIF tautomerase actio anti-inflammatione suis Revolutionibus componit. Int.Immunopharmacol. MMV: V: 849-856. View abstracto.
101. Provinciali, M.: Re: P., Donnini, A., Orlando di, P., Bartozzi, B., De Stasio, G., et Smorlesi, A. resveratrol in progressionem effectus a sua sponte in secretiori parte natium adult-II / neu transgenic mures inclusi essent. Int.J 5-20-2005 Cancri: CXV: 36-45. View abstracto.
102. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram N. P. Shishodia, S., et Takada, Y. de resveratrol, in partes praeventionis et treatment of cancer, Preclinical et orci studiis. Res Anticancer. MMIV: XXIV (5a), 2783-2840. View abstracto.
103. Walle, T., Hsieh, P., DeLegge, M. H., Oatis, J. E., Jr., et Walle, E. u nimis humilis et princeps effusio de bioavailability resveratrol, in oris homines. Metab medicamento Dispos. MMIV: XXXII: 1377-1382. View abstracto.
104. Jannin, B., Menzel, M., Berlot, J. P, Delmas, D., Lancon, A. et Latruffe, n onerariam est resveratrol, in cancer chemopreventive agente, ut cellular peltas: et cell protein plasmatic uptake. Biochem.Pharmacol. 9-15-2004: LXVIII: 1113-1118. View abstracto.
105. Evers, D. L. Wang, X, Huong: S. M., Huang, M. D., et Huang, E. S. 3,4 ',-V-Trihydroxy trans-Stilbene (resveratrol) inhibits Cytomegalovirus-virus replicationem et cellular adductus signaling. Herpesvirus hominis Res. MMIV: LXIII: 85-95. View abstracto.
106. Piver, B.: Fer, M., Vitrac, X, Merillon, JM, Dreano, Y., Berthou, Franciscus, and Lucas, D. de Involvement Cytochrome P450 in 1A2 Fungi-resveratrol, in humana iecoris et trans microsomes . Biochem.Pharmacol. 8-15-2004: LXVIII: 773-782. View abstracto.
107. Lignum S. G. Rogina B. Lavu S. Howitz, K. Helfand S. L. Turca M. et Claro D. Sirtuin activators in ludicro caloric restrictione metazoans moram senescit. Natura 8-5-2004: CDXXX, 686-689. View abstracto.
108. Olas, B., Wachowicz, B., Calvi, C., et Glowacki, R. Et in tutela effectus est resveratrol mutationes in sanguine platelet thiols adductus platinum suis Revolutionibus componit. J.Physiol Pharmacol. MMIV: LV, 467-476. View abstracto.
109. Cavallaro, A., Ainis T. Bottari: C. et Fimiani: V. resveratrol ad effectus aliquos ex solitaria et actiones totius humani sanguinis neutrophils. Res physiol. MMIII: LII: 555-562. View abstracto.
110. Kim, YA, Lee, George, Choi, TH, Rhee, SH: Park, IL, et Choi, YH Involvement de p21WAF1 / CIP1, prb, Bax et NF-kappaB per inductionem incrementum comprehensionem et apoptosis per resveratrol, in humana pulmone carcinoma A549 cellulis. Int.J.Oncol. MMIII: XXIII: 1143-1149. View abstracto.
111. Howitz MMIX Bitterman, draconem, Cohen, HY, MORSUS, DW, Lavu, S., ligno, JG, Zipkin, vide RE, Chung, P., Kisielewski, A. Zhang, LL, Scherer, B., et Sancto Claro , DA aequale est Parvus moleculo activators sirtuins extend Yersinia pestis timeo. Natura 9-11-2003: CDXXV: 191-196. View abstracto.
112. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui, Melchisua filios Saul, M., Jannin, B., Dubrez Daloz, L., Latruffe N., et Solary, C. Resveratrol, apoptosis est consociata cum Fas adductus discrimen aliquod atque in ea ratibus ac formationem ipsorum effectorum-inducens mortem significantes in universa colonia cancer cellulis. J.Biol.Chem. 10-17-2003: CCLXXVIII, 41482-41490. View abstracto.
113. Liang, C. y, Tsai, S. H. Chen, L., Lin-Shiau: S. V. et Lin, J. C. Resveratrol adductus G2, comprehensionem et per inhibitionis de CDK7 p34CDC2 kinases Carcinoma in colonia HT29 cellulis. Biochem.Pharmacol. 4-1-2003: LXV: 1053-1060. View abstracto.
114. Klinge, C. M., Risinger, S. E. Watts B. M., Beck, V. et Eder et R. et Jungbauer, A. estrogenic operatio rubrum et album vinum in posui. J Agric.Food Cham 3-26-2003: LI: 1850-1857. View abstracto.
115. Vitrac, X, Desmouliere, A., Brouillaud, B., krisa, S., Deffieux, G., Barthe famulam tuam N., Rosenbaum, J. et Merillon, W. Dividebatur autem [14C] -trans-resveratrol, in Angiospermae chemopreventive cancer et etiam textus post oris administratione mus. Sci 4-4-2003: LXXII, 2219-2233. View abstracto.
116. Levenson, AS oscilletur Gehm, BD contento, Zacharias Pearce, ST, Horiguchi, J., Simonis, LA, Daphne, E., III, Jameson, J. solitudinis atque Iordanem et estrogen receptor quod acts Resveratrol V (ER) agonist continenter exsistit, in pectus cancer cellulis transfected cum ER alpha. Int.J.Cancer 5-1-2003: CIV: 587-596. View abstracto.
117. Yu, C., Shin, S. G., Kosmeder, J. W., Pezzuto, J. M., and van Breemen, R. B. Liquid Angiospermae / spectrometric tandem massa determinatio per inhibitionis de homine isozymes Cytochrome P450-resveratrol, et III-resveratrol sulfate. Celeri Commun.Mass Spectrom. MMIII: XVII: 307-313. View abstracto.
118. Olas B. Wachowicz B. Saluk Juszczak, J. et Zielinski T. Resveratrol effectus naturalis polyphenolic compositum est vel endotoxin thrombin antiplatelet activation inductus. Thromb.Res 8-15-2002: CVII (3-4): 141-145. View abstracto.
119. Wallerath T. Deckert, G.: Ternes T. Anderson, H. Li, H., Witte, K., et Forstermann, II Resveratrol, a praesenti polyphenolic Leguminosae in vino, et amplio expressio actione de endothelial nitric cadmiae synthase. Et circulatione 9-24-2002: CVI, 1652-1658. View abstracto.
120. Sharma, et Gupta M., S. C. Longos curatio est resveratrol trans prohibet convenientiam intracerebroventricular oxidative accentus in streptozotocin adductus cognitiva indigestionem et mures inclusi essent. Sci 10-11-2002; LXXI, 2489-2498. View abstracto.
121. Holian, O., Wahid, S., pertractata notaverunt, J. M. et Attar, Raphanus sativus B. M. CARDIACUS cancer cellam proliferation per resveratrol, partes nitric cadmiae. Am.J.Physiol Gastrointest.Liver physiol MMII, CCLXXXII, G809, G816. View abstracto.
122. Potter, UT, Patterson, LH Wanogho, E., Thomas, PJ pincerna, PC, Ijaz T. Ruparelia, KC, agnus, Cornelius: Agricola: PB Stanley, LA, et de Burgo, MD de agente cancer preventative anticancer est resveratrol ad eam ab agente piceatannol cytochrome P450 enzyme CYP1B1. Br.J.Cancer 3-4-2002: LXXXVI, 774-778. View abstracto.
123. Falchetti, R., Fuggetta, M., P., Lanzilli, G.: Tricarico, M. et Ravagnan, G. Effectus resveratrol cell munus in humana immunis. Sci. 11-21-2001: LXX: 81-96. View abstracto.
124. Bhavnani BR Cecutti, A., Gerulath, A., Woolever, AC, Berco, M. antioxidant effectus de comparatione equinae estrogens, rufus vinum components, Vitaminum E et humilis-densitate lipoprotein in probucol oxidatio in postmenopausal mulieribus . Menopause. MMI, VIII, 408-419. View abstracto.
125. Bhat, K., P., Lantvit, D., Christov, K., Mehta, R. G., lunam R. C. et Pezzuto, et J. M. estrogenic antiestrogenic proprietatibus resveratrol, in tumore mammae exempla monstrabit. Res cancer. 10-15-2001: LXI: 7456-7463. View abstracto.
126. Lee, J. E. et Tutus ad socios Romanos S. Involvement Transcriptional mechanism de post-resveratrol, in in inhibitionis de CYP1A1 expressio ab pectus cancer cellulis. Biochem.Pharmacol. 10-15-2001: LXII, 1113-1124. View abstracto.
127. Bhat, P. et C. Pezzuto, et J. M. Resveratrol exhibet Citostático antiestrogenic humanae proprietatibus et endometrial ADENOCARCINOMA (Ishikawa) intermediis. Res cancer. 8-15-2001: LXI: 6137-6144. View abstracto.
128. Nicolini, G.: Rigolio, R., Miloso, M., Bertelli, A. A. et Tredici, G. apoptotic effectus anti-resveratrol, in paclitaxel, adductus est trans humano apoptosis in neuroblastoma SH SY5Y cellula-line. Neurosci.Lett. 4-13-2001, CCCII, 41-44. View abstracto.
129. Giovannini L., Migliori, M., Incitti expriment BM, Das, DK; Bertelli ut dictum est, Panichi, V.: Filippi, C., et Bertelli, A. resveratrol, in Angiospermae a vino, in reduces ischemia reperfusion injuriam rat renunculis. J Cardiovasc.Pharmacol. MMI: XXXVII: 262-270. View abstracto.
130. Chan, J. et W. Delucchi: A. B. Resveratrol est, rufus vinum constitutionis est pars, est mechanism fundatur, ex inactivator Cytochrome P450 3A4. Sci 11-10-2000: LXVII, 3103-3112. View abstracto.
131. Wang M. J., Huang, M. H., Hsieh: S. J., Jeng, S. C. et Kuo, J. S. Resveratrol inhibits interleukin VI-productio in glial cellulis corticalibus mixta in hypoxia / hypoglycemia reoxygenation sequitur. J Neuroimmunol. 1-1-2001: CXII (1-2): 28-34. View abstracto.
132. Chang, M. K Lee, B. W., et quia inservit usibus, H. H. Calcium actio et Trans-resveratrol ad modulatur cDNA expressio activum in homine, procarcinogen Cytochrome P450 1B1. Can.J.Physiol Pharmacol. MM: LXXVIII: 874-881. View abstracto.
133. Burkitt, et J. M. Duncan, J. trans-resveratrol ad effectus aeris-dependens hydroxyl formation radicitus, et DNA damnum, quod ob hydroxyl-radicalis scavenging, et ad usum eorum, glutathione, parcens mechanism de actio. Arch.Biochem.Biophys. 9-15-2000, CCCLXXXI, 253-263. View abstracto.
134. Zbikowska, H. et M. Olas: cum B. Facilisis carcinostatic actio (resveratrol, Selenium et Vitaminum E) in crebritate modulorum suaviorem sanguinis platelet adhaesionem. J Pharmacol physiol. MM: LI: 513-520. View abstracto.
135. Kirk, R. I., Deitch, A. J., Wu, J. M. et Lerea, significans primo decrescat C. M. Resveratrol lota in platelets sed certe minus habet effectum in totum platalet in cibum. Mol.Dis sanguis cellulis. MM: XXVI: 144-150. View abstracto.
136. Maradona, D., Maradona, M., Stohs: S. J., De, D. K.: Ray, S. D.: Kuszynski, C. A., Josephus, S S. et Pruess, H. G. liberum radicalis et uva semen proanthocyanidin extract: momenti in humana salutem et morbo ne. Editis 8-7-2000: CXLVIII (2-3): 187-197. View abstracto.
137. Bradamante, S., Piccinini, P., Barenghi L., Bertelli, A. A., De Jonge, R., Bamestra P et de Jong, J. W. Numquid resveratrol inducere pharmacological preconditioning? Int.J textus agere. MM: XXII: 1-4. View abstracto.
138. Naderali, E K. Doyle, J. P, et Williams, G. inducit Resveratrol vasorelaxation de mesentericap sup-Guinea porcos et femina ex Tabulae neryorum uteri. Clin Sci (London) MM: XCVIII, 537-543. View abstracto.
139. Klabunde T. Petrassi, M. H., Aream Chidon, tetendit V. B., Roman P, Kelly, M. W., et Sacchettini, J. C. humanae naturae ratio videndi transthyretin amyloideae inhibitors morbo. Struct.Biol Nat. MM, VII, 312-321. View abstracto.
140. Martinez atque J. Moreno, J. J. effectum conflictus resveratrol, in natura polyphenolic compositis, in prostaglandin et reciprocus oxygeni speciei productionem. Biochem.Pharmacol 4-1-2000: LIX: 865-870. View abstracto.
141. Subbaramaiah, K., Michaluart, P., Chung W. J., Tanabe T. Telang tuarum N. et Dannenberg, A. II, J. Resveratrol inhibits Cyclooxygenase transcription in epithelial cellulis fetus hominum. Ann.N.Y.Acad.Sci. MCMXCIX, DCCCLXXXIX: 214-223. View abstracto.
142. Dobrydneva, Y., Williams, R. L., and Blakemore P F.-Resveratrol inhibits calcii influxum trans humano thrombin-eliciebatur platelets. Br.J.Pharmacol. MCMXCIX, CXXVIII, 149-157. View abstracto.
143. Ciolino, P. et H. Gloria: C. G. de Planta-aryl hydrocarbon adductus Vertebrata CDL-resveratrol a 1A1 enzyme actio et CYP1A1 expressio. Mol.Pharmacol. MCMXCIX, LVI, 760-767. View abstracto.
144. Lin, J. et C. Tsai, Chemoprevention H. et S. et cancer cardiovascular morbus per resveratrol. MCMXCIX Proc.Natl.Sci.Counc.Repub.China B: XXIII: 99-106. View abstracto.
145. Zou, G. J., Huang, S. Z., Chen dictum est, Wei, H. B., Hsieh, C. C. Wu, J.-Ion M. Resveratrol inhibits aeris et Azo adductus compositis principiato oxidative immutatione hominum densitate lipoprotein humilis. Biochem.Mol.Biol.Int. MCMXCIX; XLVII, 1089-1096. View abstracto.
146. Rahman, medicinales progressus I. Antioxidante COPD. Ther.Adv.Respir.Dis. MMVIII, II: 351-374. View abstracto.
147. Kimura, Y., Okuda, H. et Kubo, M. Effecta rememdium sero die stilbenes seiunctis, ii profecto arachidonate metabolismi in humana degranulation polymorphonuclear leukocytes. J Ethnopharmacol. MCMXCV: XLV: 131-139. View abstracto.
148. Pars-Carneiro, J., Gonzalvez, M., Larrosa, M., Juan, Almagro, F., Aviles-Plaza, P., Parra, S., Yanez, Gasconis, FA, Ruiz, Ros, JA, Juan, Conesa prout stylus, Tomas-Barberan, FA contentum, et Espin, C. Consummatio de uva extract supplementum quibus resveratrol, decrescat oxidized LDL, et ApoB in aegris sustinentes primaria ne cardiovasculares morbo, in triplici caecorum VI-mensis sequitur, placebo-sobrie , randomized iudicium. Victus Mol.Nutr Res MMXII, LVI, 810-821. View abstracto.
149. Pars-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez, Gasconis, FA, Juan, Almagro, F., Ruiz, Ros, JA, Juan Conesa, prout stylus, Tomas-Barberan, FA contentum, et Espin, C. unus annus consummatio de uva-inflammatory et fibrinolytic nutraceutical quibus resveratrol ad meliorare status de aegris cardiovascular morbus est in prima cavendum ne existeret. J am Cardiol. 8-1-2012: CX: 356-363. View abstracto.
150. Zern, TL, ligno, Marcus Tullius, Greene, C., Occidentem, erunt KL, Liu, Y., Aggarwal, D., Shachter, NS, Fernandez, Roma e pluribus unum polyphenols regimenque manu tractare cardioprotective effectus in pre-et postmenopausal mulieres urguebant plasma reducing lipids et oxidative accentus. J Nutr. MMV: CXXXV, 1911-1917. View abstracto.
151. Piver, B., Berthou, P., Dreano, Y., et Lucam, D. differentialium per inhibitionis de homine enzymes Cytochrome P450-theta viniferin et dimer est resveratrol: collatio cum resveratrol ex alcoholized polyphenols et potiones. Sci. 7-18-2003, LXXIII, 1199-1213. View abstracto.
152. de: C. Sancti, Pietrabissa, A., Mosca, Franciscus: Pacifici atque, in G. M. Glucuronidation resveratrol, in praesenti productum naturalis uva in vinum, et in humanis iecur. Xenobiotica MM, XXX, 1047-1054. View abstracto.
153. Rosa, P. I., Zulet, M. A., Marchini: S. J., et Martinez apud J. A. Bioactive effectus in suis Revolutionibus componit venalicium in frigore hominibus. Int J Victus Sci Nutr MMXII: LXIII: 749-765. View abstracto.
154. Chang, C. C. Chen, J. et Lee, W. et B. differentialium praeceptum inactivation de enzymes ab homine CYP1 trans-resveratrol, quod mechanism, secundum ad inactivation de CYP1A2. J.Pharmacol.Exp.Ther. MMI: CCXCIX: 874-882. View abstracto.
155. Basly, J. P, Marre mortaliter, Fournier, J., PRAES Le, J. C., Habrioux, G., et Chulia, J. A. estrogenic / antiestrogenic scavenging et proprietatibus (E) - atque (z) -resveratrol. Sci. 1-21-2000: LXVI: 769-777. View abstracto.
156. Quod Mueller: Simon, S, c K, et al. Et phytoestrogens humanae proprietatibus et hostile in tenuissimum ostendam distincta agonistic estrogen receptor alpha (ERalpha) et ERbeta in humana cellulis. Sci Toxicol MMIV: LXXX: 14-25. View abstracto.
157. Boocock Song: Faust GE, Patel KR, et al. Sana me, in studio tempus dose PROLATIO pharmacokinetic voluntarii resveratrol, in potential cancer chemopreventive agente. Next cancer Epidemiol Biomarkers MMVII, XVI, 1246-52. View abstracto.
158. Lugduni, M, C Yu Toma RB, et al. Resveratrol, in rudis et vaccinia nigra pingit uaccinia eius coxit sorbitiunculas. Victus J Agric Cham MMIII: LI: 5867-70. View abstracto.
159. Trincheri NF, Nicotra G, C Follo, et al. In colorectal cancer cellulis per mortem inducit Resveratrol cellulam autem devium ducit ad usum involving lysosomal cathepsin D. Carcinogenesis MMVII: XXVIII: 922-31. View abstracto.
160. Stabat Mater F, G fuit Sale, Somenzi G, et al. Resveratrol inducit praeceptum incrementum cancer cellulis per pectus et apoptosis in metastatic de novo ceramide signaling. J FASEB MMIII: XVII: 2339-41. View abstracto.
161. Q Wang Li II, Wang XW, et al. Fas-resveratrol promovet inducit distinctionem, et ex iuris apoptosis medulloblastoma humana cellulis. Litterae apostolicae Neurosci MMIII, CCCLI, 83-6. View abstracto.
162. Culpitt SV, EF Rogers, Fenwick PS: et al. Plasmodium falciparum ruber a vino extract, resveratrol, et cristae alveolaris cytokine release per macrophages in COPD. Thorax longitudine MMIII: LVIII: 942-6. View abstracto.
163. S. pervaiz Resveratrol: de animantibus biology et vinearum. J FASEB MMIII: XVII: 1975-85. View abstracto.
164. Savaskan E, G Olivieri, Meier F; et al. Beta ex vino mixta Resveratrol amyloideo neurotoxicity tuetur. Vivamus MMIII: XLIX: 380-3. View abstracto.
165. Gao X, Deeb D, J Media, et al. Immunomodulatory actio est resveratrol: discrepant: in vitro et in vivo immunological effectus. Biol Pharmacol MMIII: LXVI: 2427-35. View abstracto.
166. Schriever C, Pendland S. L Mahady GB. Vinum rubrum, resveratrol, Chlamydia pneumoniae Gallico et nexu. MMIII ATHEROSCLEROSIS, CLXXI, 379-80. View abstracto.
167. Iobus C, Rainwater l J Byrne, McEntee MF. Resveratrol, in puritate alimentorum non ponitur intestinorum Ap tumorigenesis (min / +) murium sentitur. J Nutr MMIV, CXXXIV: 5-10. View abstracto.
168. Kim YA, Choi squalls BT, Lee YT, et al. Inhibits cellam proliferation et apoptosis est resveratrol inducit pectus humanum carcinoma MCF VII-cellulis. MMIV Oncol Rep: XI: 441-6. View abstracto.
169. Zhang Y, Jayaprakasam B, Seeram NP bafim, et al. In enzyme inhibitionis Cyclooxygenase insulin secretio et uva cutis Chardonnay suis Revolutionibus componit. Victus J Agric Cham MMIV, LII, 228-33. View abstracto.
170. Alpha Omega Opipari Jr, tan L. Boitano AE; et al. Amet in turpis ovarii autophagocytosis Resveratrol effecerunt. Res cancer MMIV: LXIV: 696-703. View abstracto.
171. La-Zeid Abou El-AM Mowafy. Diversus recognition ab humana estrogen receptor-resveratrol isomers a beta: nam quod hypothetica dynamics Stereoselective ligand binding. Chirality MMIV: XVI: 190-5. View abstracto.
172. Meng X, P Maliakal Lu S, et al. Et plasma urinariorum campester of quercetin resveratrol, et in hominibus, mures, mures majores post ingestion de uva sucus et pura suis Revolutionibus componit. Victus J Agric Cham MMIV, LII, 935-42. View abstracto.
173. Hascalik S: Celik Domine, Turkoz ego, et al. Resveratrol, in constituentes constent vinum rubrum Angiospermae: protegit a ischemia reperfusion-damnum de ovaria. Obsido MMIV Gynecol Obstet, LVII, 218-23. View abstracto.
174. A. ahmad Clementis MV Hanif IM S. pervaiz Resveratrol inhibits Mauris effecerunt apoptosis hominum coetu Cocci creando per cellulas leukaemia nonpermissive mortis supplicium. Res cancer MMIV, LXIV, 1452-9. View abstracto.
175. Li W, M Seifert, Xu ego, Hock B. de Asia estrogenic est potentia contradictionis estradiol, Tamoxifen, bisphenol A-resveratrol, et duo in vitro bioassays. Int ambiunt MMIV, XXX, 329-35. View abstracto.
176. Martin AR, Villegas Ego La Casa C, CA de la Lastra Resveratrol, in Angiospermae de uva exprimitur, non oxidative damnum suppressit atque incitat apoptosis durante diluculo colonic inflammatio mures inclusi essent. Biol Pharmacol MMIV, LXVII, 1399-410. View abstracto.
177. Szewczuk aequales, Forti L. Stivala LA, Penning TM.COX I-resveratrol est a precursor inactivator mediata, sed non Cox II: I, electionem selectivam A naturam demonstrant machinariam appropinquant ad Consilium COXUS agentibus. J Mol Cham MMIV, CCLXXIX: 22727-37. View abstracto.
178. Wang Z, Huang y Zou J; et al. De platelet aggregatio effectus rufus vinum, et vinum Angiospermae resveratrol in vitro et in vivo. Int J Mol Biol MMII: IX: 77-9. View abstracto.
179. Mokni M, F Limam, Elkahoui S, et al. Cardioprotective fortis effectus est resveratrol, in Angiospermae vinum rubeum in cordibus vestris post rat singulis ischemia / reperfusion injuriam. Arcus Biol Biophys MMVII, CDLVII 1-6. View abstracto.
180. Elmali N, O Baysal: A Harma, et al. Effectus est resveratrol, in inflammatione arthritis. Inflammatio MMVII, XXX 1-6. View abstracto.
181. Bujanda L, M Barcina, Garcia: de Ioannis Gutierrez, V; et al. Vocatus-effecerunt mortalitatis effectus est resveratrol ad iecur per extrinsecus incidunt quinque mures aureos. Acta Gastroenterol MMVI: VI: XXXV. View abstracto.
182. Qui annuntiant bona! JA, Nabu draconem, Price US, et al. Resveratrol ad meliorare sanitas super mures insistere, et salvos summus calorie victu. Natura MMVI, CDXLIV, 337-42. View abstracto.
183. Murias M, N Handl, Jacob, Erker T; et al. II-resveratrol analoga Cyclooxygenase inhibitors ut electionem selectivam, actio-structuram et summa necessitudo. J Med Cham MMIV: XII: 5571-8. View abstracto.
184. Hwang D, NH Fischer, Jang BC, et al. Planta est expressio inducible Cyclooxygenase et proinflammatory cytokines Angiospermae lactones per macrophages in inhibitionis de correlates MAP kinases. Res Biol Biophys viaticum MCMXCVI, CCXXVI: 810-8 .. View abstracto.
185. Takada ego, Bhardwaj A, P Potdar, Aggarwal BB. Anti-inflammatione nonsteroidal facultatem agentium differunt in supprimunt atramentum NF-kappaB activation, inhibitionis de expressio Cyclooxygenase-II et cyclin D1 et abrogata cellam proliferation de tumore. Alpha MMIV, XXIII, 9247-58. View abstracto.
186. M. Goldberg, Yan C, G, J soleas. Lolium multiflorum trium vinum actis polyphenols matrices ab alia tribus in sanus subditis. Clin Biol MMIII: XXXVI: 79-87 .. View abstracto.
187. Docherty JJ Fu MM Stiffler BS, et al. Herpesvirus hominis Resveratrol inhibitionis de replicationem. Res MCMXCIX Herpesvirus hominis; XLIII, 145-55. View abstracto.
188. Umbracula, s TE DEUM LAUDAMUS TE Tyulmenkov, Jernigan SC Klinge CM. Resveratrol acts ut a mixta agonist / parem estrogen receptor alpha et beta. MM Endocrinology, CXLI, 3657-67.
189. Piver B, F Berthou, Dreano ego, D. Lucae CYP3A est Planta, et CYP1A CYP2E1 resveratrol actiones a vino, et aliis components non volatile rubrum. Litterae apostolicae Toxicol MMI: CXXV: 83-91. View abstracto.
190. Vasta gravatus BP Porter TD. Resveratrol vetat obscura squalene precursor hominum. Res Nutr MMI: XXI: 747-53.
191. Ego Kozuki, Miura U, C. Yagasaki Resveratrol tumultus premit hepatoma extra cellulam suam proliferativa action.Cancer Litterae apostolicae anti-MMI, CLXVII, 151-6. View abstracto.
192. Cicero A Vincentii F, B Duranton, et al. Proliferativa est effectus anti-resveratrol, vinum, et uvas, et expressi naturalis pars in hominum Colonia cancer cellulis. Litterae apostolicae MM cancer, CLVIII, 85-91.
193. Jacobus JS, Troxel AB, Evans J; et al. Astragalus a randomized iudicium pro treatment of calidum fulguris cum mulieres in historia pectus cancer. Clin J Oncol MMI, XIX, 2739-45. View abstracto.
194. M-McNary Holmes, II Baldovino AC, Jr. Chemopreventive consociata cum proprietatibus quae trans-resveratrol ad IkappaB activation de enzyme inhibitionis. Res cancer MM; LX, 3477-83. View abstracto.
195. Bertelli Rom Giovannini L, D Giannessi, et al. Naturalis industria Saccharum Antiplatelet Resveratrol in vino. Int J textus React MCMXCV, XVII, 1-3. View abstracto.
196. Gehm BD McAndrews Babylon, Chien PY, Jameson JL. Resveratrol, vinum, et uvas, et expressi in polyphenolic compositis, est quia agonist estrogen receptor. Kessinger Publishing Acad Sci Phil U S A MCMXCVII; XCIV: 14138-43. View abstracto.
197. Carbonem, N, P Costelli, Baccino FM; et al. Resveratrol, in vino praesens sit productum naturalis, decrescit in tumore augmentum exemplar rat tumore. Res Biol Biophys viaticum MCMXCIX, CCLIV, 739-43. View abstracto.
198. Huang C, M WY, Goranson A, Dong I. Resveratrol cellula plus reprimit transmutatio apoptosis et introducimur per viam p53-dependens. MCMXCIX Carcinogenesis: XX: 237-42. View abstracto.
199. M. Davy, Melby C, D Beske, et al. Oat non ponitur consummatio quiete ambulances et fortuita, XXIV h arteriarum sanguinem pressura in normalis sanguinem pressura homines summus gradu ut ego hypertension. J Nutr MMII: CXXXII: 394-8 .. View abstracto.
200. Chen CK, Alleluia, R. Asciak. Et vagae Quercetin Vasorelaxing actionem Resveratrol aortam mus. Pharmacol MCMXCVI Deut: XXVII: 363-6. View abstracto.
201. Bertelli A Bertelli AA Gozzini A L. Giovannini Resveratrol concentratione et carne plasma pharmacological et operationem. Res Medicinae Exp Clin MCMXCVIII: XXIV: 133-8. View abstracto.
202. C. pace, Asciak, Hahn S: Diamandis EP, et al. Et vinum rubeum-resveratrol, et phenolics trans humano platelet aggregatio et quercetin obstructionum eicosanoid summam complectitur: in tutela effectus in coronarius cor morbo. Clin Chim Acta MCMXCV, CCXXXV, 207-19. View abstracto.
203. Bertelli Rom Giovannini L. W facere digneris: et al. Antiplatelet Resveratrol Cis-operationem. Res Medicinae Exp Clin MCMXCVI: XXII: 61-3. View abstracto.
204. Asciak pace, RC, Rounova Domine, Hahn se, et al. Et vinum uva sucus est sanus modulators de platelet aggregatio in rebus humanis. Clin Chim Acta MCMXCVI, CCXLVI, 163-82. View abstracto.
205. Jang M, E, Cai, Udeani GO, et al. Operatio Resveratrol chemopreventive arcu, naturalis ex uvis. Scientia MCMXCVII, CCLXXV, 218-20. View abstracto.
206. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol, moleculo cuius venit dies? Et abierunt? Clin Biol MCMXCVII: XXX: 91-113. View abstracto.
207. Agri Res Svc: Dr. Dux ethnobotanical et databases de phytochemical. www.ars-grin.gov/duke (November III Accessed MCMXCIX).
208. Et a Review Products Naturalis fatta et comparationes. Sancti Ludovici, MO: Wolters Kessinger Publishing Co., MCMXCIX.
209. Nutritius S: Tacitus VE versatur. Tacitus 's Herbal Honesta: A Rector ut sens usus herbarum Related et remediis. 3 ed., Binghamton, NY: Haworth eget Press, MCMXCIII.
210. Newall CA, O Anderson, Philpson JD. Herbal Medicine: A nam Healthcare Professionals. London, UK: De pharmaceutical Press, MCMXCVI.
211. Tacitus VE versatur. Arbitrio herbis. Binghamton, NY: Pharmaceutical Products Press, MCMXCIV.
212. Blumenthal M, ed. Latin German Edition Commission E: therapeutica Rector ut Donec medicinam. Trans. S. Klein. Boston, MA: National American Consilii, MCMXCVIII.
213. Bibliotheca medicinae ex herba medicinae usu. Exoniae UK: De Europae Co-op Phytother, MCMXCVII.

From Review - 09/30/2020